Several single-center stroke studies have suggested that lower Hb predicts poorer rehabilitation gains, but most prior investigations focused on global outcome scales (e.g., mRS, discharge destination) rather than standardized balance performance (Berg Balance Scale; He et al., 2020; Li et al., 2016; Naess et al., 2019). The gene discussed is GSTM1; the disease is stroke disorder.